{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:48:21Z","timestamp":1791276501605,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T00:00:00Z","timestamp":1388448000000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.blre.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T07:41:19Z","timestamp":1379576479000},"page":"279-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"title":["Management of sickle cell disease from childhood through adulthood"],"prefix":"10.1016","volume":"27","author":[{"given":"Julie","family":"Kanter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kruse-Jarres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2013.09.001_bb0005","first-page":"364","article-title":"Sickle cell disease; a general overview","volume":"62","author":"Schnog","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.327.7424.1151","article-title":"Managing sickle cell disease","volume":"327","author":"Claster","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2013.09.001_bb0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.blre.2013.09.001_bb0020","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0025","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.bbmt.2009.10.001","article-title":"Severe sickle cell disease \u2014 pathophysiology and therapy","volume":"16","author":"Buchanan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2013.09.001_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mrdd.20124","article-title":"National evaluation of US newborn screening system components","volume":"12","author":"Therrell","year":"2006","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.blre.2013.09.001_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0040","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0045","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0050","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jcp.2008.058859","article-title":"Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005\u20137","volume":"62","author":"Streetly","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2013.09.001_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpeds.2008.09.052","article-title":"Trends in pediatric sickle cell disease-related mortality in the United States, 1983\u20132002","volume":"154","author":"Yanni","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2013.09.001_bb0065","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.2007-0018","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life","volume":"121","author":"Adamkiewicz","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.blre.2013.09.001_bb0070","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med"},{"issue":"90\u20132","key":"10.1016\/j.blre.2013.09.001_bb0075","first-page":"5","article-title":"Managing the acutely ill adult with sickle cell disease","volume":"21","author":"Brown","year":"2012","journal-title":"Br J Nurs"},{"key":"10.1016\/j.blre.2013.09.001_bb0080","first-page":"532","article-title":"Pathophysiological insights in sickle cell disease","volume":"134","author":"Odi\u00e8vre","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.blre.2013.09.001_bb0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nm0409-364","article-title":"Neutrophil sandwiches injure the microcirculation","volume":"15","author":"Looney","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0090","author":"Novartis AG Iron Health Alliance"},{"key":"10.1016\/j.blre.2013.09.001_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1179\/146532808X335624","article-title":"Growth and nutritional status of children with homozygous sickle cell disease","volume":"28","author":"Al-Saqladi","year":"2008","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.blre.2013.09.001_bb0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/ers.11.64","article-title":"Asthma morbidity and treatment in children with sickle cell disease","volume":"5","author":"Anim","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0105","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PEC.0b013e31815a05e2","article-title":"Management of vasoocclusive pain events in sickle cell disease","volume":"23","author":"Ellison","year":"2007","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.blre.2013.09.001_bb0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11920-007-0080-0","article-title":"Anxiety and depression in children and adolescents with sickle cell disease","volume":"9","author":"Benton","year":"2007","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.blre.2013.09.001_bb0115","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2003-11-3758","article-title":"Survival of children with sickle cell disease","volume":"103","author":"Quinn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0120","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2013.09.001_bb0125","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.21476","article-title":"The excess burden of stroke in hospitalized adults with sickle cell disease","volume":"84","author":"Strouse","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MOH.0b013e3280ec5243","article-title":"The pathophysiology, prevention, and treatment of stroke in sickle cell disease","volume":"14","author":"Wang","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0135","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2011-05-349621","article-title":"Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0140","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/WNL.50.6.1678","article-title":"Cognitive screening examinations for silent cerebral infarcts in sickle cell disease","volume":"50","author":"DeBaun","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2013.09.001_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0150","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.0b013e3181a110da","article-title":"Utilization of TCD screening for primary stroke prevention in children with sickle cell disease","volume":"72","author":"Armstrong-Wells","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2013.09.001_bb0155","first-page":"241","article-title":"Healthcare provision for sickle cell disease: challenges for the African context","volume":"5","author":"Dennis-Antwi","year":"2008","journal-title":"Divers. Health Soc. Care"},{"key":"10.1016\/j.blre.2013.09.001_bb0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajh.21359","article-title":"Asthma management: reinventing the wheel in sickle cell disease","volume":"84","author":"Morris","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.11213","article-title":"Asthma is associated with increased mortality in individuals with sickle cell anemia","volume":"92","author":"Boyd","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2013.09.001_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.20336","article-title":"Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance","volume":"79","author":"Ballas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0180","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V89.5.1787","article-title":"Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease","volume":"89","author":"Vichinsky","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jwh.2006.15.146","article-title":"Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project","volume":"15","author":"McClish","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.blre.2013.09.001_bb0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/ehm.11.61","article-title":"The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease","volume":"4","author":"Strouse","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0200","first-page":"1","article-title":"Evidence-based management of sickle cell disease in the emergency department","volume":"13","author":"Glassberg","year":"2011","journal-title":"Emerg Med Pract"},{"key":"10.1016\/j.blre.2013.09.001_bb0205","doi-asserted-by":"crossref","first-page":"a1397","DOI":"10.1136\/bmj.a1397","article-title":"Management of sickle cell disease","volume":"337","author":"de Montalembert","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2013.09.001_bb0210","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2013.09.001_bb0215","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(02)09776-3","article-title":"New therapies in sickle cell disease","volume":"360","author":"Vichinsky","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2013.09.001_bb0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pbc.24178","article-title":"Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children","volume":"59","author":"Strouse","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2013.09.001_bb0225","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0230","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0235","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pbc.24100","article-title":"Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia","volume":"59","author":"Alvarez","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2013.09.001_bb0240","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pbc.23365","article-title":"Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG phase III clinical trial","volume":"59","author":"McGann","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2013.09.001_bb0245","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood-2012-03-419879","article-title":"Impact of hydroxyurea on clinical events in the BABY HUG trial","volume":"120","author":"Thornburg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0250","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3476(05)82006-2","article-title":"Effects of a long-term transfusion regimen on sickle cell-related illnesses","volume":"125","author":"Styles","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2013.09.001_bb0255","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMct1004810","article-title":"Iron-chelating therapy for transfusional iron overload","volume":"364","author":"Brittenham","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.09.001_bb0260","first-page":"CD007477","article-title":"Deferasirox for managing transfusional iron overload in people with sickle cell disease","author":"Meerpohl","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2013.09.001_bb0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1067\/mpd.2002.122498","article-title":"Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke","volume":"140","author":"Scothorn","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2013.09.001_bb0270","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood-2010-01-261123","article-title":"Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease","volume":"117","author":"Hulbert","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0275","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1586\/ehm.09.33","article-title":"Current strategies for the management of children with sickle cell disease","volume":"2","author":"de Montalembert","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0285","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/asheducation-2011.1.434","article-title":"Primary prophylaxis in sickle cell disease: is it feasible? Is it effective?","volume":"2011","author":"Thompson","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2013.09.001_bb0290","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/ehm.11.23","article-title":"Stem-cell transplantation in children and adults with sickle cell disease: an update","volume":"4","author":"Khoury","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0295","first-page":"CD007001","article-title":"Hematopoietic stem cell transplantation for children with sickle cell disease","author":"Oringanje","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2013.09.001_bb0300","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2007-07-089144","article-title":"Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void","volume":"111","author":"Solomon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.09.001_bb0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2013.09.001_bb0310","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpainsymman.2009.12.027","article-title":"A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease","volume":"40","author":"Taylor","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.blre.2013.09.001_bb0315","doi-asserted-by":"crossref","first-page":"158","DOI":"10.12968\/bjon.2009.18.3.39043","article-title":"Barriers to effective pain management in sickle cell disease","volume":"18","author":"Wright","year":"2009","journal-title":"Br J Nurs"},{"key":"10.1016\/j.blre.2013.09.001_bb0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0033-3549(04)50214-5","article-title":"Rural\/urban differences in access to and utilization of services among people in Alabama with sickle cell disease","volume":"118","author":"Telfair","year":"2003","journal-title":"Public Health Rep"},{"key":"10.1016\/j.blre.2013.09.001_bb0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1748-0361.2000.tb00435.x","article-title":"Socioeconomic distress and health status: the urban-rural dichotomy of services utilization for people with sickle cell disorder in North Carolina","volume":"16","author":"Haque","year":"2000","journal-title":"J Rural Health"},{"key":"10.1016\/j.blre.2013.09.001_bb0330","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1542\/peds.110.S3.1322","article-title":"Implementing transitions for youth with complex chronic conditions using the medical home model","volume":"110","author":"Kelly","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.blre.2013.09.001_bb0335","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajh.21676","article-title":"Sickle cell disease in the United States: looking back and forward at 100years of progress in management and survival","volume":"85","author":"Prabhakar","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0340","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.21880","article-title":"Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research","volume":"86","author":"Treadwell","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0345","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2013.09.001_bb0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/jpdn.2002.30930","article-title":"A natural history study of adolescents and young adults with sickle cell disease as they transfer to adult care: a need for case management services","volume":"17","author":"Wojciechowski","year":"2002","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.blre.2013.09.001_bb0355","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1043454209350155","article-title":"From cradle to commencement: transitioning pediatric sickle cell disease patients to adult providers","volume":"27","author":"Doulton","year":"2010","journal-title":"J Pediatr Oncol Nurs"},{"key":"10.1016\/j.blre.2013.09.001_bb0360","doi-asserted-by":"crossref","first-page":"310","DOI":"10.12968\/hmed.2010.71.6.48435","article-title":"Moving young people with sickle cell disease from paediatric to adult services","volume":"71","author":"Howard","year":"2010","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.blre.2013.09.001_bb0365","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2013.09.001_bb0370","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.moh.0000219658.57915.d4","article-title":"Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia","volume":"13","author":"Sadelain","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2013.09.001_bb0375","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1871529X10909040271","article-title":"A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis","volume":"9","author":"Hebbel","year":"2009","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.blre.2013.09.001_bb0380","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10739680590925691","article-title":"Platelet-vessel wall interactions in the microcirculation","volume":"12","author":"Tailor","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.blre.2013.09.001_bb0385","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease","volume":"359","author":"Gladwin","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X1300057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X1300057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:42:55Z","timestamp":1715989375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X1300057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0268960X1300057X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2013.09.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of sickle cell disease from childhood through adulthood","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}